Open Access<p>Knockdown of lncRNA MCM3AP-AS1 Attenuates Chemoresistance of Burkitt Lymphoma to Doxorubicin Treatment via Targeting the miR-15a/EIF4E Axis</p>
Author(s) -
Chao Guo,
Ming Gong,
Zhenling Li
Publication year - 2020
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s248698
Subject(s) - cancer research , gene knockdown , chemistry , apoptosis , transfection , doxorubicin , carcinogenesis , microrna , viability assay , in vivo , biology , medicine , chemotherapy , biochemistry , gene , microbiology and biotechnology
The long-noncoding RNA MCM3AP-AS1 has been shown to participate in the tumorigenesis and growth of several types of cancer, but little is known about the role of MCM3AP-AS1 in the chemoresistance of lymphoma.